1 Min Read
Oct 27 (Reuters) - Novartis Ag
* Novartis says Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.